|
E2F3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.709040E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.031600E-01 |
| Normal-vs-Stage2 |
1.824610E-01 |
| Normal-vs-Stage3 |
2.592400E-02 |
| Normal-vs-Stage4 |
2.303900E-03 |
| Stage1-vs-Stage2 |
2.609800E-01 |
| Stage1-vs-Stage3 |
1.384460E-02 |
| Stage1-vs-Stage4 |
3.079200E-03 |
| Stage2-vs-Stage3 |
6.882400E-01 |
| Stage2-vs-Stage4 |
2.602200E-01 |
| Stage3-vs-Stage4 |
3.295200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.110800E-01 |
| Normal-vs-AfricanAmerican |
2.589200E-01 |
| Normal-vs-Asian |
9.129600E-02 |
| Caucasian-vs-AfricanAmerican |
9.697200E-01 |
| Caucasian-vs-Asian |
3.290400E-01 |
| AfricanAmerican-vs-Asian |
3.973200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.363200E-01 |
| Normal-vs-Female |
1.071820E-02 |
| Male-vs-Female |
2.452400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.454840E-01 |
| Normal-vs-Extreme_Weight |
8.302600E-01 |
| Normal-vs-Obese |
5.360200E-02 |
| Normal-vs-Extreme_Obese |
5.315600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.038000E-02 |
| Normal_Weight-vs-Obese |
7.131400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.752200E-01 |
| Extreme_Weight-vs-Obese |
1.255550E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.749600E-01 |
| Obese-vs-Extreme_Obese |
5.417600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.655500E-03 |
| Normal-vs-Age(41-60Yrs) |
8.883700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.082600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.359400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.376300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.571600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.464200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.997000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.506040E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.416300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.804000E-01 |
| Normal-VS-Type2 PRCC |
1.729510E-02 |
| Normal-VS-KIRP CIMP |
1.586400E-04 |
| Normal-VS-Unclassified PRCC |
3.829600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.539600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.02949999999325E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.318000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.918390E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.879450E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.361790E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.432000E-01 |
| Normal-vs-N1 |
2.018300E-04 |
| Normal-vs-N2 |
2.282200E-01 |
| N0-vs-N1 |
3.207400E-04 |
| N0-vs-N2 |
2.736400E-01 |
| N1-vs-N2 |
3.053600E-01 |
|
|
